"Switching adalimumab from syringe to pen. Expected outcomes"

Expert Opin Biol Ther. 2012 Jun;12(6):805-6. doi: 10.1517/14712598.2012.676033. Epub 2012 Mar 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Syringes*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents